


Healthcare News Roundup: Cardiology
HSMN NewsFeed - 21 Feb 2014
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
HSMN NewsFeed - 20 Feb 2014
Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker
Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker
HSMN NewsFeed - 17 Feb 2014
Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion(R)
Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion(R)
HSMN NewsFeed - 6 Feb 2014
St. Jude Medical Announces First US Patient Implant of Non-Surgical, Leadless Cardiac Pacemaker
St. Jude Medical Announces First US Patient Implant of Non-Surgical, Leadless Cardiac Pacemaker
HSMN NewsFeed - 3 Feb 2014
Neovasc Inc. Announces Successful First Human Implant of Tiara(TM) Transcatheter Mitral Valve
Neovasc Inc. Announces Successful First Human Implant of Tiara(TM) Transcatheter Mitral Valve
HSMN NewsFeed - 28 Jan 2014
St. Jude Medical Announces Organizational and Executive Leadership Changes
St. Jude Medical Announces Organizational and Executive Leadership Changes
HSMN NewsFeed - 28 Jan 2014
ReCor Medical Announces Major Advances with Its Ultrasound-Based Renal Denervation System
ReCor Medical Announces Major Advances with Its Ultrasound-Based Renal Denervation System
HSMN NewsFeed - 27 Jan 2014
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
HSMN NewsFeed - 27 Jan 2014
St. Jude Medical Announces Implant of World’s First Leadless Pacemaker in the UK
St. Jude Medical Announces Implant of World’s First Leadless Pacemaker in the UK
HSMN NewsFeed - 24 Jan 2014
SafeSept(R) Needle Free Transseptal Guidewire Receives FDA Market Clearance
SafeSept(R) Needle Free Transseptal Guidewire Receives FDA Market Clearance
HSMN NewsFeed - 17 Jan 2014
Medtronic CoreValve(R) System Obtains Early FDA Approval on Exceptional Clinical Performance
Medtronic CoreValve(R) System Obtains Early FDA Approval on Exceptional Clinical Performance
HSMN NewsFeed - 15 Jan 2014
Federal Jury Finds Medtronic CoreValve Willfully Infringes Edwards' Transcatheter Valve Patent
Federal Jury Finds Medtronic CoreValve Willfully Infringes Edwards' Transcatheter Valve Patent
HSMN NewsFeed - 13 Jan 2014
Esperion Therapeutics Announces the Appointment of Antonio M. Gotto Jr., M.D., DPhil, as Director
Esperion Therapeutics Announces the Appointment of Antonio M. Gotto Jr., M.D., DPhil, as Director
HSMN NewsFeed - 7 Jan 2014
Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension
Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension
HSMN NewsFeed - 6 Jan 2014
Medtronic Announces Acquisition of TYRX, INC., Developer of Solutions for Surgical Site Infections
Medtronic Announces Acquisition of TYRX, INC., Developer of Solutions for Surgical Site Infections
HSMN NewsFeed - 6 Jan 2014
Boston Scientific Names Craig Thompson, M.D. As New Chief Medical Officer, Interventional Cardiology
Boston Scientific Names Craig Thompson, M.D. As New Chief Medical Officer, Interventional Cardiology
